Hypoglycemic Agents: all 3,927 studies that test it
Page 33 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy SubjectsCompletedNCT00842556Phase 1
- Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) WomenCompletedNCT00842140Not applicable
- Insulin Therapy in the Hospital Comparing Two ProtocolsCompletedNCT00841919Phase 4
- Comparison of the Effects of Repaglinide and Metformin on Glucose ExcursionsStatus unknownNCT00832481Not applicable
- Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 DiabetesCompletedNCT00832182Phase 3
- Treat-to-target Trial of Basal Insulin in Post-transplant HyperglycemiaCompletedNCT00830297Phase 2
- Safety of Pioglitazone for Hematoma Resolution In Intracerebral HemorrhageCompletedNCT00827892Phase 2
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCompletedNCT00825253Phase 1
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedNCT00824668Phase 1
- Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin MonotherapyCompletedNCT00822211Phase 3
- Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesCompletedNCT00821977Phase 2/3
- Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic PatientsCompletedNCT00819325Phase 4
- Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired PatientsCompletedNCT00818571Phase 1/2
- Molecular Mechanisms of Type 2 Diabetes MellitusCompletedNCT00816218Phase 4
- Pioglitazone Versus Metformin in Type 2 DiabetesCompletedNCT00815399Phase 4
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsCompletedNCT00813228Phase 1
- Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of ConceptCompletedNCT00811681Phase 3
- A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat MalariaTerminatedNCT00811356Phase 1
- A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp TrialCompletedNCT00810589Phase 1
- Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same TimeTerminatedNCT00809536Phase 1
- Treatment With hOKT3gamma1(Ala-Ala) in T1DMTerminatedNCT00806572Phase 2
- Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20CompletedNCT00803972Phase 1
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
- PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With ClomipheneCompletedNCT00795808Phase 4
- Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV InsulinCompletedNCT00795015Phase 4
- Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCompletedNCT00791895Phase 4
- To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 SuspensionCompletedNCT00790153Phase 1
- Detemir Energy Expenditure StudyCompletedNCT00788840Phase 4
- Insulin Glargine Combination Therapies in Type II DiabeticsCompletedNCT00783744Phase 3
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed ConditionsCompletedNCT00778466Not applicable
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting ConditionsCompletedNCT00778427Not applicable
- A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat MealCompletedNCT00778349Not applicable
- Cognitive Side Effects of Commonly Prescribed Medications in Pediatric MigraineWithdrawnNCT00777218Not applicable
- Bioequivalence Study of Glimepiride 1mg Tablets Under Fed ConditionsCompletedNCT00776620Not applicable
- Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)Status unknownNCT00776607Not applicable
- Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting ConditionsCompletedNCT00776490Not applicable
- Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot StudyWithdrawnNCT00775164Phase 4
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
- Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)CompletedNCT00771693Phase 4
- Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.CompletedNCT00771004Phase 2
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
- Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular DiseaseCompletedNCT00770575Phase 2
- Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.CompletedNCT00770497Phase 2
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)CompletedNCT00770081Phase 3
- Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary StudyCompletedNCT00769158Phase 1
- Topiramate for Binge Eating Disorder Among AdolescentsCompletedNCT00768677Not applicable
- A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentCompletedNCT00768209Phase 1
- Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNCT00766441Phase 4
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)CompletedNCT00765830Phase 3
- Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery PatientsCompletedNCT00764712Not applicable
- Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical WardsCompletedNCT00764556Phase 2
- Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
- Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762190Phase 3
- Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCompletedNCT00760448Phase 1
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnNCT00754689Phase 3
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
- Pharmacokinetics and Safety of Intravenous Topiramate in Adult PatientsCompletedNCT00753493Phase 1
- A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCompletedNCT00752466Phase 1
- How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?Status unknownNCT00749047Phase 4
- Insulin Effects on Metabolism and Cardiovascular Function in Type 2 DiabetesStatus unknownNCT00747409Phase 4
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving RosiglitazoneCompletedNCT00746174Phase 4
- Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsCompletedNCT00745914Not applicable
- Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis PatientsCompletedNCT00745225Phase 4
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
- Sitagliptin in Renal Transplant RecipientsCompletedNCT00740363Phase 4
- Variation in Sulphonylurea Response in Type 2 DiabetesTerminatedNCT00738088Phase 4
- PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy VolunteersCompletedNCT00733785Phase 1
- Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose ToleranceStatus unknownNCT00733174Phase 4
- Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKACompletedNCT00732524Phase 4
- Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMWithdrawnNCT00732147Not applicable
- Bone Turnover in Type 2 Diabetes PatientsStatus unknownNCT00732121Phase 4
- Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated DizzinessWithdrawnNCT00732108Not applicable
- Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)CompletedNCT00728351Phase 3
- Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 DiabetesCompletedNCT00725036Phase 3
- Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.Status unknownNCT00724542Not applicable
- Carotid Atherosclerosis: MEtformin for Insulin ResistAnce StudyCompletedNCT00723307Phase 4
- Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTerminatedNCT00722917Phase 2
- Anti-Inflammatory Effects of PioglitazoneCompletedNCT00722631Not applicable
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic SyndromeCompletedNCT00721552Not applicable
- Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.CompletedNCT00720577Early Phase 1
- Metformin in Children With Motor DeficitCompletedNCT00720161Not applicable
- Effect of Pioglitazone on Inflammation in Cystic FibrosisCompletedNCT00719381Phase 1
- Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)CompletedNCT00708578Phase 4
- A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.CompletedNCT00703755Phase 2
- Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic ControlCompletedNCT00701831Phase 4
- Endothelial Effects of Basal Insulin: Detemir Versus GlargineCompletedNCT00699686Phase 4
- Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative StressStatus unknownNCT00699322Phase 4
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsCompletedNCT00698230Phase 2
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationStatus unknownNCT00696982Not applicable
- A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)CompletedNCT00696826Phase 1
- Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)CompletedNCT00694759Not applicable
- Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed InsulinCompletedNCT00693771Phase 4
- A Study of the Functional Magnetic Resonance Imaging Response to Leptin and PramlintideStatus unknownNCT00691158Not applicable